Pioneering healthcare company opens North Wales headquarters to spearhead long-term expansion
A company that has pioneered an alternative approach to
traditional latex and non-latex surgical gloves is using a
six-figure equity investment from Finance Wales to spearhead the
next phase of its growth strategy.
Having recently gained a place on the multi-million pound NHS
Supply Chain Framework, Leanvation’s range of surgical gloves are
now available to NHS trusts throughout the UK for the first
Leanvation was founded in 2013 by former healthcare executives
Dr Jonathan Day, Tony Downes and Steve King and Finance Wales’
investment will now see the company open its new headquarters in
It will also enable Leanvation to fund all-important trials with
more NHS trusts, establish its infrastructure and build up the
stocks it will need to fulfil customer orders.
Leanvation has taken advantage of the latest advances in
materials technology to develop and manufacture its range of
surgical gloves. They can be used in the majority of surgical
procedures, offering a range of clinical benefits. Leanvation’s aim
is to reduce the risk of potentially fatal allergic reactions while
saving hospitals money. This comes at a time when reducing costs
across the NHS has never been more important.
“These are exciting times for Leanvation as we now have a proven
product that’s gaining traction in our key markets. We’re
delighted to have become an approved supplier to the NHS as we’re a
small company and it’s a big vote of confidence in both our
products and our innovative approach.
“We’ll be building on this success from our new Welsh
headquarters as we commence trials with more NHS trusts.
Finance Wales’ investment will enable Leanvation to focus on
innovation while stepping up production. We can also build up
our stocks and target international growth markets,” Leanvation’s
Managing Director, Jonathan Day explained.
Jerry Mobbs, Deputy Portfolio Manager at Finance Wales worked
with Jonathan and his he team to tailor an investment to suit the
growth challenges Leanvation now faces. He said: “Jonathan,
Tony and Steve have capitalised on their expertise and experience
in the healthcare industry to create a best-in-class product having
secured equity funding to set up their innovative young company
three years ago. Leanvation now has the potential for even
greater success with Finance Wales’ backing.
“Finance Wales’ investment will now enable them to continue
building on these foundations and firmly establish Leanvation as a
leader in its field. Winning a place on the NHS framework and
opening its new headquarters in Wales are both significant steps
forward for the company in its long-term growth journey.”
Having started up in the North West of England, Leanvation will
continue to build on the strong links it has established with
surgeons and hospitals in the region.
With surgical gloves playing a critical role in infection
control and being a key NHS spend area, Leanvation’s latex-free
Surgical, UltraSensitive and Spot gloves have so far impressed
customers. Supported by no fewer than four brand new products
in 2016, Leanvation are able to offer potential quality
improvements, which include the inspection of every single glove
for defects prior to use. This ability to improve efficiency and
reduce costs means that interest across the NHS in Leanvation is
firmly set to continue.
MC Vanguard acted as corporate finance advisors to Leanvation
and its lawyers were Gateley plc. Hill Dickinson LLP acted
for Finance Wales.